Kenneth Cusi (K Cusi, Ken Cusi)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 45

Top Topics

Insulin Resistance

African American

Clinical Practice

Top Venues

Diabetes spectrum : a publication of the American Diabetes Association

Alimentary pharmacology & therapeutics

The Journal of clinical endocrinology and metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Kenneth Cusi
Nonalcoholic Fatty Liver Disease in Diabetes: A Call to Action. Diabetes spectrum : a publication of the American Diabetes Association 37 (1) (2024)
Alina M Allen, Michael R Charlton, Kenneth Cusi, Stephen A Harrison, Kris V Kowdley, Mazen Noureddin, Jay H Shubrook
Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting. Postgraduate medicine (2024)
Idoia Genua, Kenneth Cusi
Pharmacological Approaches to Nonalcoholic Fatty Liver Disease: Current and Future Therapies. Diabetes spectrum : a publication of the American Diabetes Association 37 (1) (2024)
Kenneth Cusi, Jeff Budd, Eric Johnson, Jay Shubrook
Making Sense of the Nonalcoholic Fatty Liver Disease Clinical Practice Guidelines: What Clinicians Need to Know. Diabetes spectrum : a publication of the American Diabetes Association 37 (1) (2024)
Alina M Allen, Michael R Charlton, Kenneth Cusi, Stephen A Harrison, Kris V Kowdley, Mazen Noureddin, Jay H Shubrook
Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting. Postgraduate medicine 136 (3) (2024)
Alina M Allen, Michael R Charlton, Kenneth Cusi, Stephen A Harrison, Kris V Kowdley, Mazen Noureddin, Jay H Shubrook
Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting. Postgraduate medicine 136 (3) (2024)
Kenneth Cusi, Jeff Budd, Eric Johnson, Jay Shubrook
Making Sense of the Nonalcoholic Fatty Liver Disease Clinical Practice Guidelines: What Clinicians Need to Know. Diabetes spectrum : a publication of the American Diabetes Association 37 (1) (2024)
Idoia Genua, Kenneth Cusi
Pharmacological Approaches to Nonalcoholic Fatty Liver Disease: Current and Future Therapies. Diabetes spectrum : a publication of the American Diabetes Association 37 (1) (2024)
Alina M Allen, Michael R Charlton, Kenneth Cusi, Stephen A Harrison, Kris V Kowdley, Mazen Noureddin, Jay H Shubrook
Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting. Postgraduate medicine (2024)
Juan Patricio Nogueira, Kenneth Cusi
Role of Insulin Resistance in the Development of Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: From Bench to Patient Care. Diabetes spectrum : a publication of the American Diabetes Association 37 (1) (2024)
Juan Patricio Nogueira, Kenneth Cusi
Role of Insulin Resistance in the Development of Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: From Bench to Patient Care. Diabetes spectrum : a publication of the American Diabetes Association 37 (1) (2024)
Kenneth Cusi
Nonalcoholic Fatty Liver Disease in Diabetes: A Call to Action. Diabetes spectrum : a publication of the American Diabetes Association 37 (1) (2024)
Alina M Allen, Zobair M Younossi, Emmanuel A Tsochatzis, William Alazawi, Shira Zelber-Sagi, Juan Pablo Arab, Kenneth Cusi, Jeffrey Victor Lazarus
Measuring NAFLD models of care. Nature reviews. Gastroenterology & hepatology (2023)
Juan M Munoz Pena, Kenneth Cusi
Post-Transplant Diabetes Mellitus: Recent Developments in Pharmacological Management of Hyperglycemia. The Journal of clinical endocrinology and metabolism (2023)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 57 (3) (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Issacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics (2022)
Kenneth Cusi
A Simple Test to Identify the Risk of NASH and Cirrhosis in People With Obesity or Diabetes: The Time to Screen Is Now. The Journal of clinical endocrinology and metabolism 107 (7) (2022)
Phil A Hart, Yogish C Kudva, Dhiraj Yadav, Dana K Andersen, Yisheng Li, Frederico G S Toledo, Fuchenchu Wang, Melena D Bellin, David Bradley, Randall E Brand, Kenneth Cusi, William Fisher, Kieren Mather, Walter G Park, Zeb Saeed, Robert V Considine, Sarah C Graham, Jo Ann Rinaudo, Jose Serrano, Mark O Goodarzi
A reduced pancreatic polypeptide response is associated with new onset pancreatogenic diabetes versus type 2 diabetes. The Journal of clinical endocrinology and metabolism (2022)
Srilaxmi Kalavalapalli, Eddison Godinez Leiva, Romina Lomonaco, Xiaofei Chi, Sulav Shrestha, Rachel Dillard, Jeffery Budd, Jessica Portillo Romero, Christina Li, Fernando Bril, George Samraj, John Pennington, Petra Townsend, Frank Orlando, Shwetha Shetty, Lydia Mansour, Lorena Rodrigues Silva-Sombra, Pierre Bedossa, John Malaty, Diana Barb, Matthew J Gurka, Kenneth Cusi
Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients with Type 2 Diabetes and NAFLD. The Journal of clinical endocrinology and metabolism (2022)
Renata Belfort-DeAguiar, Romina Lomonaco, Kenneth Cusi
Approach to the Patient with Nonalcoholic Fatty Liver Disease. The Journal of clinical endocrinology and metabolism (2022)
Yonghui Wu, Xi Yang, Heather Lynne Morris, Matthew J Gurka, Elizabeth A Shenkman, Kenneth Cusi, Fernando Bril, William Troy Donahoo
Noninvasive Diagnosis of Nonalcoholic Steatohepatitis and Advanced Liver Fibrosis Using Machine Learning Methods: Comparative Study With Existing Quantitative Risk Scores. JMIR medical informatics 10 (6) (2022)
Diana Barb, Kenneth Cusi
Response to: "Nonalcoholic fatty liver disease in diabetes: Overlooked or just ignored?" Obesity (Silver Spring, Md.) 30 (5) (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 57 (3) (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 57 (3) (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 57 (3) (2022)
Tom Waddell, Alexandre Bagur, Diogo Cunha, Helena Thomaides-Brears, Rajarshi Banerjee, Daniel J Cuthbertson, Emily Brown, Kenneth Cusi, Jean-Pierre Després, Michael Brady
Greater ectopic fat deposition and liver fibroinflammation and lower skeletal muscle mass in people with type 2 diabetes. Obesity (Silver Spring, Md.) 30 (6) (2022)
Huilin Tang, Stephen E Kimmel, Steven M Smith, Kenneth Cusi, Weilong Shi, Matthew J Gurka, Almut G Winterstein, Serena Jingchuan Guo
Comparable Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1RAs in Asian and White Populations: An Updated Meta-analysis of Results From Randomized Outcome Trials. Diabetes care 45 (4) (2022)
Jeffrey Victor Lazarus, Quentin Mark Anstee, Hannes Hagström, Kenneth Cusi, Helena Cortez-Pinto, Henry E Mark, Michael Roden, Emmanuel A Tsochatzis, Vincent Wai-Sun Wong, Zobair M Younossi, Shira Zelber-Sagi, Manuel Romero, Jörn Markus Schattenberg
Defining comprehensive models of care for NAFLD. Nature reviews. Gastroenterology & hepatology 18 (10) (2021)
Fasiha Kanwal, Jay H Shubrook, Zobair Younossi, Yamini Natarajan, Elisabetta Bugianesi, Mary E Rinella, Stephen A Harrison, Christos Mantzoros, Kim Pfotenhauer, Samuel Klein, Robert H Eckel, Davida Kruger, Hashem El-Serag, Kenneth Cusi
Preparing for the NASH epidemic: A call to action. Obesity (Silver Spring, Md.) 29 (9) (2021)
Chandani Patel Chavez, Kenneth Cusi, Sushma Kadiyala
The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD. The Journal of clinical endocrinology and metabolism (2021)
Diana Barb, Enrico M Repetto, Michael E Stokes, Sudha S Shankar, Kenneth Cusi
Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease. Obesity (Silver Spring, Md.) 29 (11) (2021)
Francesco Rubino, Silvia Sabatini, Fabrizia Carli, Melania Gaggini, Fernando Bril, Renata Belfort-DeAguiar, Vincenzo Positano, Diana Barb, Sushma Kadiyala, Stephen A Harrison, Kenneth Cusi
PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH. Liver international : official journal of the International Association for the Study of the Liver 41 (11) (2021)
Fasiha Kanwal, Jay H Shubrook, Zobair M Younossi, Yamini Natarajan, Elisabetta Bugianesi, Mary E Rinella, Stephen A Harrison, Christos S Mantzoros, Kim Pfotenhauer, Samuel Klein, Robert H Eckel, Davida Kruger, Hashem El-Serag, Kenneth Cusi
Preparing for the NASH Epidemic: A Call to Action. Diabetes care 44 (9) (2021)
Kenneth Cusi
Time to Include Nonalcoholic Steatohepatitis in the Management of Patients With Type 2 Diabetes. Diabetes care 43 (2) (2020)
Romina Lomonaco, Eddison Godinez Leiva, Fernando Bril, Sulav Shrestha, Lydia Mansour, Jeff Budd, Jessica Portillo Romero, Siegfried Schmidt, Ku-Lang Chang, George Samraj, John Malaty, Katherine Huber, Pierre Bedossa, Srilaxmi Kalavalapalli, Jonathan Marte, Diana Barb, Danielle Poulton, Nada Fanous, Kenneth Cusi
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening. Diabetes care 44 (2) (2020)
Fernando Bril, Diana Julie Leeming, Morten Asser Karsdal, Srilaxmi Kalavalapalli, Diana Barb, Jinping Lai, Matthew Rabe, Kenneth Cusi
Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes. Diabetes care 42 (7) (2019)
Fernando Bril, Michael J McPhaul, Michael P Caulfield, Virginia C Clark, Consuelo Soldevilla-Pico, Roberto J Firpi-Morell, Jinping Lai, Carmen H Tong, Charles M Rowland, Kenneth Cusi
Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes. Diabetes care 43 (2) (2019)
Fernando Bril, Diane M Biernacki, Srilaxmi Kalavalapalli, Romina Lomonaco, Sreevidya K Subbarayan, Jinping Lai, Fermin Tio, Amitabh Suman, Beverly K Orsak, Joan Hecht, Kenneth Cusi
Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial. Diabetes care 42 (8) (2019)
J Leey, Kenneth Cusi
Editorial: diabetes, obesity and clinical inertia-the recipe for advanced NASH. Alimentary pharmacology & therapeutics 47 (8) (2019)
Kenneth Cusi, Fernando Bril, Diana Barb, David C Polidori, Sue Sha, Atalanta Ghosh, Kristin Farrell, Nishanth E Sunny, Srilaxmi Kalavalapalli, Jeremy H Pettus, Theodore P Ciaraldi, Sunder Mudaliar, Robert R Henry
Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes. Diabetes, obesity & metabolism 21 (4) (2018)
Fernando Bril, Laura Millán, Srilaxmi Kalavalapalli, Michael J McPhaul, Michael P Caulfield, Ibon Martinez-Arranz, Cristina Alonso, Pablo Ortiz Betes, José M Mato, Kenneth Cusi
Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. Diabetes, obesity & metabolism 20 (7) (2018)
Fernando Bril, Kenneth Cusi
Response to Comment on Bril et al. Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients. Diabetes Care 2018;41:187-192. Diabetes care 41 (9) (2018)
Kenneth Cusi
Pioglitazone for the treatment of NASH in patients with prediabetes or type 2 diabetes mellitus. Gut 67 (7) (2017)
Fernando Bril, Paola Portillo-Sanchez, I-Chia Liu, Srilaxmi Kalavalapalli, Kristin Dayton, Kenneth Cusi
Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients. Diabetes care 41 (1) (2017)